Skip to main content
Future Journal of Pharmaceutical Sciences

Table 6 Robustness results of the proposed methods

From: Simultaneous spectrophotometric determination of recombined sofosbuvir, ledipasvir and paracetamol together as commonly repurposed drugs for COVID-19 treatment

Parameters

Zero order

First derivative

LDV

SOF

PAR

Recovery ± RSD

Recovery ± RSD

Different device

100.5 ± 0.321

101.3 ± 0.425

98.7 ± 0.377

Wavelength*

99.6 ± 0.445

99.91 ± 0.753

100.16 ± 0.663

Different solvent suppliers

101.2 ± 1.182

100.8 ± 0.482

101.1 ± 1.033

  1. *peak amplitude was recorded at the selected wavelengths ± 0.2 nm for the proposed methods
Back to article page